RAD51 and cancer: RAD51 inhibitor significantly potentiated cytotoxicity of CPT in all cancer cell types tested (Figure 4) and the impact of RAD51 inhibitor on CPT-induced cytotoxicity was mostly synergistic (Figure S3).